Kathryn Beiser

VP, Global Communications at Eli Lilly

In this role, Beiser oversees all aspects of the company's corporate communications strategy, including internal and external corporate communications, media relations, crisis management, executive communications, digital and social media, and corporate brand and reputation management.

Beiser has a strong background in healthcare communications, most recently serving as senior vice president and chief communications officer for Kaiser Permanente. Before joining Kaiser Permanente, Beiser held the role of senior advisor with APCO Worldwide and also served as global chair, corporate practice, for Edelman Public Relations Worldwide. Earlier, she served as executive vice president, corporate communications, for Hilton Worldwide, and was vice president of corporate communications for Discover Financial Services. Beiser has also worked for several of the world's most well-known public relations firms, including Burson-Marsteller, Golin and Hill & Knowlton where she focused on healthcare and other clients in highly regulated industry sectors.

Beiser is a member and a former trustee of the Arthur W. Page Society, the professional organization of chief communication officers, as well as a former trustee of the Institute for Public Relations. She currently serves on the boards of Bright Pink, a nonprofit organization that helps to save lives from breast and ovarian cancer by empowering women to know their risk and manage their health proactively, and Break the Cycle, a nonprofit organization aimed at ending domestic violence and promoting healthy relationships among teenagers. Beiser holds a bachelor's degree in political science from Northwestern University and a master's degree from the Medill School of Journalism at Northwestern.

Location

Indianapolis, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Eli Lilly

234 followers

Eli Lilly and Company engages in the discovery, development, manufacture, and sale of products in pharmaceutical products business segment.